MetLife, Inc. (NYSE:MET) Shares Bought by Xponance Inc.

Xponance Inc. raised its holdings in MetLife, Inc. (NYSE:MET) by 2.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 83,807 shares of the financial services provider’s stock after acquiring an additional 2,022 shares during the period. Xponance Inc.’s holdings in MetLife were worth $5,542,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. FWL Investment Management LLC acquired a new stake in MetLife in the 4th quarter valued at about $26,000. Studio Investment Management LLC acquired a new stake in shares of MetLife during the 4th quarter worth approximately $29,000. Planned Solutions Inc. acquired a new stake in shares of MetLife during the 4th quarter worth approximately $28,000. Eagle Bay Advisors LLC acquired a new stake in shares of MetLife during the 2nd quarter worth approximately $28,000. Finally, Quintet Private Bank Europe S.A. acquired a new stake in shares of MetLife during the 3rd quarter worth approximately $28,000. Institutional investors and hedge funds own 89.81% of the company’s stock.

MetLife Price Performance

Shares of MET opened at $71.11 on Friday. MetLife, Inc. has a twelve month low of $48.95 and a twelve month high of $74.68. The firm’s fifty day simple moving average is $71.12 and its 200-day simple moving average is $66.77. The firm has a market capitalization of $51.41 billion, a price-to-earnings ratio of 38.86, a PEG ratio of 0.53 and a beta of 1.04. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.53.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a return on equity of 19.48% and a net margin of 2.36%. The company had revenue of $18.72 billion for the quarter, compared to analyst estimates of $18.07 billion. Equities analysts forecast that MetLife, Inc. will post 8.71 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on MET. Morgan Stanley raised their price target on shares of MetLife from $80.00 to $82.00 and gave the stock an “overweight” rating in a report on Monday, April 15th. Wells Fargo & Company increased their price objective on shares of MetLife from $83.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. Piper Sandler increased their price objective on shares of MetLife from $74.00 to $85.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $70.00 to $80.00 in a research report on Monday, January 8th. Finally, Keefe, Bruyette & Woods increased their price objective on shares of MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $79.23.

Insider Buying and Selling

In related news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares in the company, valued at approximately $4,174,893.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other MetLife news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction on Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the transaction, the executive vice president now directly owns 57,768 shares in the company, valued at $4,174,893.36. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the transaction, the insider now owns 146,981 shares in the company, valued at $10,567,933.90. The disclosure for this sale can be found here. 0.32% of the stock is owned by company insiders.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.